X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15319) 15319
Book Review (3649) 3649
Publication (1342) 1342
Book Chapter (178) 178
Book / eBook (120) 120
Conference Proceeding (48) 48
Dissertation (37) 37
Magazine Article (14) 14
Government Document (3) 3
Journal / eJournal (3) 3
Web Resource (3) 3
Data Set (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13285) 13285
humans (11462) 11462
female (9135) 9135
antineoplastic agents, hormonal - therapeutic use (5539) 5539
oncology (5078) 5078
breast neoplasms - drug therapy (4351) 4351
middle aged (3801) 3801
male (3754) 3754
breast cancer (3680) 3680
animals (3514) 3514
aged (3040) 3040
adult (2998) 2998
tamoxifen (2901) 2901
cancer (2420) 2420
tamoxifen - therapeutic use (2352) 2352
breast neoplasms - pathology (2146) 2146
antineoplastic agents, hormonal - pharmacology (2122) 2122
treatment outcome (1905) 1905
estrogen (1727) 1727
postmenopausal women (1679) 1679
endocrinology & metabolism (1591) 1591
care and treatment (1567) 1567
breast neoplasms - metabolism (1439) 1439
expression (1431) 1431
chemotherapy, adjuvant (1401) 1401
women (1378) 1378
antineoplastic agents, hormonal - adverse effects (1374) 1374
research (1316) 1316
chemotherapy (1300) 1300
antineoplastic agents, hormonal - administration & dosage (1299) 1299
aged, 80 and over (1243) 1243
prognosis (1222) 1222
health aspects (1216) 1216
medicine & public health (1207) 1207
therapy (1172) 1172
analysis (1130) 1130
mice (1127) 1127
hormonal-regulation (1119) 1119
prostate cancer (1119) 1119
endocrine therapy (1106) 1106
risk factors (1103) 1103
obstetrics & gynecology (1083) 1083
rats (1061) 1061
abridged index medicus (1049) 1049
prostatic neoplasms - drug therapy (1042) 1042
receptors, estrogen - metabolism (1042) 1042
tamoxifen - pharmacology (1038) 1038
hormones (968) 968
breast neoplasms - genetics (948) 948
cell line, tumor (924) 924
biochemistry & molecular biology (915) 915
carcinoma (884) 884
pharmacology & pharmacy (881) 881
aromatase inhibitors (877) 877
antineoplastic combined chemotherapy protocols - therapeutic use (874) 874
disease-free survival (862) 862
postmenopause (858) 858
immunohistochemistry (820) 820
time factors (796) 796
drug therapy (780) 780
neoplasm staging (772) 772
estrogen-receptor (762) 762
drug resistance, neoplasm (757) 757
aromatase inhibitors - therapeutic use (754) 754
article (751) 751
breast neoplasms - mortality (747) 747
cell biology (746) 746
tumors (730) 730
gene expression (727) 727
cells (726) 726
gene-expression (726) 726
retrospective studies (722) 722
randomized-trial (720) 720
hormonal therapy (706) 706
urology & nephrology (704) 704
survival (665) 665
tamoxifen - adverse effects (662) 662
physiological aspects (658) 658
progesterone (658) 658
tamoxifen - administration & dosage (657) 657
surgery (654) 654
risk (648) 648
pregnancy (641) 641
prostatic neoplasms - pathology (634) 634
testosterone (632) 632
breast neoplasms - surgery (618) 618
hormonal-therapy (615) 615
neoplasms, hormone-dependent - drug therapy (614) 614
apoptosis (608) 608
menopause (605) 605
metastasis (604) 604
growth (594) 594
follow-up studies (592) 592
androgen antagonists - therapeutic use (591) 591
breast-cancer (591) 591
hematology, oncology and palliative medicine (590) 590
survival analysis (571) 571
anastrozole (570) 570
receptor (567) 567
receptors (567) 567
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (69) 69
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Online Resources - Online (8) 8
UofT at Mississauga - Stacks (6) 6
St. Michael's Hospital - Stacks (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Gerstein Science - Periodical Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Scarborough Hospital - General (2) 2
St Josephs Health Centre - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Women's College Hospital - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Royal Ontario Museum - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Toronto East General Hospital - Online (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14968) 14968
French (198) 198
Japanese (93) 93
Spanish (79) 79
German (74) 74
Russian (47) 47
Chinese (42) 42
Italian (40) 40
Portuguese (34) 34
Hungarian (24) 24
Polish (11) 11
Czech (9) 9
Danish (8) 8
Dutch (6) 6
Croatian (4) 4
Finnish (3) 3
Korean (3) 3
Romanian (3) 3
Serbian (3) 3
Slovak (2) 2
Slovenian (2) 2
Swedish (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
Hebrew (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
2003, Methods in enzymology, ISBN 9780121822675, Volume 364., xliv, 536 p., [20] p. of plates
Nuclear Receptors are inducible transcription factors that mediate complex effects on development, differentiation and homeostasis. They regulate the... 
Complexes récepteur-ligand | Receptor-ligand complexes | Nuclear receptors (Biochemistry) | Récepteurs nucléaires (Biochimie) | Hormone receptors | Handbooks, manuals, etc
Book
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5529 - 5537
Purpose TAnDEM is the first randomized phase III study to combine a hormonal agent and trastuzumab without chemotherapy as treatment for human epidermal growth... 
TRIAL | AROMATASE INHIBITOR | THERAPY | ONCOLOGY | SERUM HER-2/NEU | TAMOXIFEN | RESISTANCE | HER2 | COMBINATION | ESTROGEN-RECEPTOR | ENDOCRINE TREATMENT | Receptors, Estrogen - blood | Triazoles - administration & dosage | Triazoles - adverse effects | Confidence Intervals | Postmenopause - drug effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antibodies, Monoclonal, Humanized | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Metastasis | Adenocarcinoma - metabolism | Statistics, Nonparametric | Aged, 80 and over | Female | Drug Administration Schedule | Administration, Oral | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Adenocarcinoma - secondary | Biomarkers, Tumor - blood | Disease-Free Survival | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Breast Neoplasms - pathology | Survival Analysis | Breast Neoplasms - mortality | Aged | Infusions, Intravenous | Nitriles - adverse effects | Receptors, Progesterone - blood | Receptor, ErbB-2 - blood | Trastuzumab | Adenocarcinoma - mortality | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 10/2008, Volume 100, Issue 19, pp. 1380 - 1388
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, pp. e45767 - e45767
Introduction: Estrogens regulate the proliferation of normal and neoplastic breast epithelium. Although the intracellular mechanisms of estrogens in the breast... 
MAMMARY EPITHELIAL ACINI | GROWTH-FACTOR RECEPTOR | ACTIVATION | CANCER CELLS | E-SCREEN ASSAY | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | ENDOCRINE DISRUPTION | BISPHENOL-A | PROLIFERATION | LUMEN FORMATION | Estradiol - analogs & derivatives | Receptors, Estrogen - metabolism | Epithelial Cells - metabolism | Estrogens - pharmacology | Gene Expression - drug effects | Receptors, G-Protein-Coupled - metabolism | Epithelial Cells - drug effects | Humans | Estrogen Antagonists - pharmacology | Immunoblotting | Receptors, Progesterone - genetics | Mammary Glands, Human - metabolism | Quinolines - pharmacology | Estrogen Receptor beta - metabolism | Estrogen Receptor beta - genetics | Cell Transformation, Neoplastic - genetics | Tumor Suppressor Proteins - genetics | Estrogen Receptor alpha - metabolism | Female | Trefoil Factor-1 | Cell Culture Techniques | Estrogen Receptor beta - antagonists & inhibitors | Estradiol - pharmacology | Mammary Glands, Human - drug effects | Phenols - pharmacology | Cell Line | Mammary Glands, Human - cytology | Receptors, Estrogen - genetics | Receptors, Estrogen - antagonists & inhibitors | Estrogen Receptor alpha - antagonists & inhibitors | Reverse Transcriptase Polymerase Chain Reaction | Cell Transformation, Neoplastic - metabolism | Estrogen Receptor Modulators - pharmacology | Microscopy, Confocal | Estrogen Receptor alpha - genetics | Parabens - pharmacology | Receptors, G-Protein-Coupled - antagonists & inhibitors | Benzhydryl Compounds - pharmacology | Receptors, G-Protein-Coupled - genetics | Cell Transformation, Neoplastic - drug effects | Estrogens, Non-Steroidal - pharmacology | Benzodioxoles - pharmacology | Models | Bisphenol-A | Estradiol | Analysis | Transformation | Epithelial cells | Estrogens | Estrogen | Estrogen receptors | 17β-Estradiol | Carcinogenesis | Morphogenesis | Signal transduction | Carcinogens | Xenoestrogens | Mammary gland | Clearing | Deformation mechanisms | Cultures | Breast cancer | Gene expression | Epithelium | Studies | Bisphenol A | Sex hormones | Medical prognosis | Pharmacy | Morphology | Phenols | Breast | Disruption | Three dimensional models | Cancer | Apoptosis | Index Medicus
Journal Article